The present data indicated that none of the patients with ESCC had HER2 amplification and/or MSI-H status or PI3KCA mutation in Iran; nevertheless, this topic in ESCC requires further investigation. This evidence concerns the gene ERBB2 and esophageal squamous cell carcinoma.